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Abstract: Over the past decade, the vast amount of information generated through structural and 
biophysical studies of GPCRs has provided unprecedented mechanistic insight into the complex 
signalling behaviour of these receptors. With this recent information surge, it has also become 
increasingly apparent that in order to reproduce the various effects that lipids and membranes exert 
on the biological function for these allosteric receptors, in vitro studies of GPCRs need to be 
conducted under conditions that adequately approximate the native lipid bilayer environment. In 
the first part of this review, we assess some of the more general effects that a membrane environment 
exerts on lipid bilayer-embedded proteins such as GPCRs. This is then followed by the consideration 
of more specific effects, including stoichiometric interactions with specific lipid subtypes. In the 
final section, we survey a range of different membrane mimetics that are currently used for in vitro 
studies, with a focus on NMR applications. 
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1. Introduction 
G protein-coupled receptors (GPCRs) are 7-transmembrane helix receptors, which are present 
in all eukaryotic organisms and have homologues in bacteria and archaea. With approximately 800 
individual members, GPCRs form one of the largest protein families encoded in the human genome 
[1]. GPCRs play key roles at virtually all levels of intercellular communication, regulating biological 
processes from cell growth to synaptic signal transmission. Due to their physiological importance 
and their good accessibility as cell surface receptors, GPCRs are one of the most important drug 
targets today and still harbour great pharmacological potential [2]. In recent decades, our 
understanding of GPCRs has greatly advanced. Especially the determination of by now over 350 
GPCR structures by x-ray crystallography and cryo-EM (see, e.g., GPCRdb.org) has led to fascinating 
insights into the molecular details of these receptors (Figure 1A). The complementation of these 
structural insights with biophysical techniques, including NMR (e.g., Imai 2020) [3], single-molecule 
fluorescence (e.g., Lamichhane 2020) [4] and HDX-MS (e.g., Du 2019) [5], provides us today with an 
expanding mechanistic understanding of GPCR activation and signalling (Figure 1B). 
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Figure 1. (A) Structural basis of GPCR activation. The binding of an agonist (green) induces 
conformational changes in the GPCR (blue), which allows the latter to interact with cytoplasmic 
coupling partners (CCPs), such as the heterotrimeric G protein depicted (orange/beige/yellow). In the 
resulting ternary complex, TM6 and TM5 (cyan) have moved out from the receptor helix bundle. This 
opens a cytoplasmic cavity in the receptor, which accommodates the CCP. The figure was designed 
with the crystal structures of the β2 adrenergic receptor (β2AR) in inactive form bound to antagonist, 
and in active, agonist-bound ternary state (PDB accession codes: 3NYA, 3SN6, 6EG8). (B) Model of 
the conformational equilibrium of a GPCR based on 19F NMR studies of the β1 adrenergic receptor 
(β1AR)). Under physiological conditions, GPCRs adapt a complex ensemble of conformational states 
that are in exchange with each other. I1 and I2 in this model are two inactive states of the β1AR, that 
exchange at high frequencies on a ms–μs time scale. The pre-active receptor state A is marked by an 
opening of the intracellular cavity of the β1AR. AG- reflects a pre-coupled state of the β1AR, in which 
a CCP binds to an inactive conformation of the receptor. AG+ represents the fully active state of the 
GPCR, in which the CCP binds into the cytoplasmic cavity of the receptor that is opened by the 
outward movement of TM6. The binding of a ligand or CCP can shift this conformational equilibrium 
and can thus guide GPCR activation by conformational selection. Ligand efficacy was in this context, 
e.g., found to correlate well with increased exchange kinetics and the population of more active states 
[6,7]. 
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Building on this progress, it is today increasingly appreciated that the membrane environment 
of GPCRs can significantly influence the structure, dynamics and function of the receptors. As ever 
more studies shed light on the interactions between GPCRs and the surrounding lipid bilayer, the 
great complexity of this relationship becomes evident. In this review, we attempt a dissection and 
organisation of this complexity. We elaborate on both the biological diversity of lipid membranes and 
the plethora of physical interactions between lipid bilayers and embedded GPCRs. We furthermore 
provide an overview of the current state and the latest advancements in mimicking lipid membranes 
for in vitro studies of GPCRs. In this context, we discuss different membrane mimetics in regard to 
the membrane features they can resemble and their compatibility with different structural and 
biophysical techniques. 
2. Cellular Trafficking of Membrane Lipids and GPCRs 
A hallmark of eukaryotic cells is their extensive network of intracellular membrane systems. 
These membrane systems compartmentalise the interior of the cell into the chemically separated and 
distinct spaces of the cytoplasm, vesicles and different organelles [8]. Apart from differences in the 
chemical composition of their aqueous phases, these compartments are also marked by a tremendous 
chemical heterogeneity of their separating lipid membranes [9,10]. 
In eukaryotic cells, more than 1000 different lipid species come together to form the different 
lipid membranes [11]. The vast majority of those lipids are synthesised in the membrane of the 
endoplasmic reticulum (ER), including most glycerophospholipids, ceramides (the precursors of 
sphingolipids) and sterols [9]. The ER is also the primary site for the incorporation of unsaturated 
acyl chains into membrane lipids [12]. Newly synthesised lipids are then trafficked through the cell 
in vesicular membranes. 
Most membrane lipids pass at some point the Golgi apparatus. The Golgi is a centre for 
membrane lipid modification and further trafficking, and in this context is especially important for 
the synthesis and glycosylation of sphingolipids [9,13,14]. Membrane lipids are eventually trafficked 
to the plasma and organellar membranes. Even having reached their destined locations, membrane 
lipids can still be extensively modified or degraded [9]. Consequently, the lipid composition of 
cellular membranes can vary greatly between distinct membrane systems. The composition can also 
rapidly change over time, as many lipid species are being chemically modified as an integral part of 
cellular signalling pathways [15]. 
The synthesis and trafficking of membrane lipids and GPCRs follow similar routes. GPCRs are 
conventionally understood in their role as cell surface receptors, residing in the plasma membranes 
of eukaryotic cells [16,17]. It is, however, important to bear in mind that every GPCR has been a part 
of various cellular membrane systems over the course of its lifetime. GPCRs are co-translationally 
inserted into the membrane of the ER [18,19]. They are then trafficked in vesicles along the secretory 
pathway of the cell, passing the membranes of the ERGIC and the Golgi apparatus [20], before 
reaching the plasma membrane. Towards the end of their lifetime, GPCRs are internalised from the 
cell surface into the membranes of endosomes [21]. These can later fuse with lysosomes, where the 
receptors are eventually degraded [22]. Beyond this “classical” lifecycle of GPCRs as cell surface 
receptors, an increasing body of studies finds GPCRs being terminally trafficked to organellar 
membranes [23–25]. Several GPCRs have in this context been found to be localised additionally or 
exclusively to the membranes of, e.g., the nuclear envelope or mitochondria (for an extensive review 
on organellar GPCRs, see Jong 2018) [26]. The different subcellular localisations of GPCRs imply 
significant variations in the lipid environments of the receptors, which might play decisive roles in 
shaping GPCR activation and signalling in a membrane specific manner. 
3. Interactions of GPCRs with Their Membrane Environment 
GPCRs are integral membrane proteins (IMPs) that have a correspondingly intimate relationship 
with lipid membranes as their immediate physical environment. This relationship is complex in many 
regards. Beyond the chemical heterogeneity of cellular membranes discussed above, it is the 
extensive spectrum of interactions between GPCRs and the surrounding membrane that remains 
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difficult to capture. These interactions range from bulk physical properties that a lipid membrane 
exerts on a GPCR, to specific and stoichiometric interactions between a receptor and individual lipid 
molecules. In this chapter, we discuss the effects that interactions with both the bulk of a lipid 
membrane and individual membrane lipids can have on the structure and function of GPCRs. 
3.1. General Membrane Effects on GPCRs 
In terms of their spatial dimensions, lipid membranes have a span of approximately 5 nm in the 
z dimension (orthogonal to the x,y plane or lateral dimension of the membrane; see Figure 2). The 
hydrophobic hydrocarbon core, formed by the acyl chains of the membrane lipids, occupies 
approximately 3 nm of the total thickness. It is flanked by respectively approximately 1 nm of 
interface region, where the polar head groups of the membrane lipids are in contact with the aqueous 
phases, separated by the lipid membrane (see Figure 2) [27]. This spatial organisation creates a 
complex physicochemical profile of the GPCR environment and is accompanied by a variety of effects 
and forces that have direct implications for membrane-embedded GPCRs. The complex profile of 
lipid membranes is in vivo further complemented by the asymmetry the two lipid leaflets with regard 
to their chemical composition and geometry. In this review, we will not discuss this asymmetry and 
its implications in great detail. However, excellent reviews of this topic can be found in, e.g., van 
Meer, 2011 and Fadeel and Xue, 2015 [28,29]. 
 
Figure 2. Schematic overview of important interactions of GPCRs with their membrane environment. 
On the left, general membrane effects are depicted. π: common lateral pressure profile in the z 
dimension of a lipid bilayer. While the lateral pressure is generally positive in the hydrocarbon core, 
it is inversed to strong tensions in the carbonyl region. Ψtot: electric potential across a cellular 
membrane. The graph depicts the sum of the individual potentials ΔΨ (transmembrane potential), Ψs 
(surface potential of the lipid headgroups) and Ψi (potential in the core of the membrane). The cartoon 
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is inspired by Honig (1986) [30]. Membrane curvature: the curvature of membranes can range from 
near zero to strong membrane-invaginations and highly curved vesicular membranes. Hydrophobic 
mismatch: the difference in hydrophobic thickness between a lipid bilayer and the TMDs of a GPCR 
can strongly affect the structure and dynamics of the latter. On the right, examples of specific lipid–
GPCR interactions are illustrated. Cholesterol: one important stoichiometric interaction partner of 
many GPCRs is cholesterol. The figure shows the crystal structure of the human β2 adrenergic 
receptor (blue) in complex with cholesterol molecules (green) (PDB accession code: 2RH1). 
Headgroup interactions: in the interface region of a membrane, GPCRs interact with lipid 
headgroups. Several of these interactions have been shown to occur in a lipid-specific and 
stoichiometric way. The figure shows a model of a PIP2 molecule (green), forming a ternary complex 
with a GPCR (blue) and a heterotrimeric G protein (orange). The figure was based on findings by Yen 
et al., 2018 [31] and was designed with crystal structures of the β2 adrenergic receptor and a 
heterotrimeric G protein (PDB accession codes: 3SN6, 6EG8). Unsaturated acyl chains: double bonds 
in the membrane lipid tails confer distinct physical properties. On the one hand, unsaturated acyl 
chains can reduce the packing density and other general membrane properties. On the other hand, 
the distinct chemical properties of unsaturated acyl chains may allow for specific interactions with 
GPCRs, which could in turn influence the activation of the regarding receptors. Unsaturated acyl 
chains, as in the lipid POPC (dark green), could, e.g., stabilize more active conformations of a GPCR 
(PDB accession code: 3SN6), while saturated acyl chains, as in the lipid DPPC, might favour inactive 
conformations (PDB accession code: 2YCW). 
3.1.1. Mechanical Forces in the Bilayer 
A lipid bilayer is in simple terms a 2D array of lipid molecules. This ordered assembly yields a 
stratification of chemical moieties in the lateral dimension. The forces that result from the homotypic 
interactions of these moieties, cooperatively build up to considerable pressures and tensions in the 
x,y plane of the lipid bilayer. This so-called lateral pressure is a general characteristic of every lipid 
bilayer. In the hydrocarbon core of the bilayer, repulsion between the hydrocarbon lipid tails is the 
dominating intermolecular force. This repulsion can give rise to lateral pressures up to 500 bar. 
Towards the interface region, attracting forces between the carbonyls dominate, generating strong 
tensions between 1000 and 2000 bar. The head group region of the bilayer is then again usually 
dominated by intermolecular repulsion between negatively charged phosphate moieties [32–34]. 
These interactions give rise to lateral pressure profiles that look for most bilayers comparable to the 
one depicted in Figure 2 (cf. π). This profile can, however, vary significantly with the composition of 
the corresponding lipid bilayer. In the hydrocarbon core of the bilayer, unsaturated acyl chains and 
cholesterol are the main modulators of lateral pressure [32,33,35]. Unsaturated acyl chains occupy 
more space in the lateral dimension than their saturated counterparts and consequently lead to 
increased pressures between the acyl chains [36,37]. Cholesterol, in contrast, seems to have more 
complex but no less pronounced effects on the pressure profile [38]. The lipid head group 
composition of a bilayer can furthermore decisively influence the lateral pressure in the interface 
region [37,39]. Cellular membranes are furthermore asymmetric lipid bilayers, which can lead to 
correspondingly highly asymmetric lateral pressure profiles [40]. 
IMPs are directly exposed to the lateral pressure of the surrounding lipid bilayer and changes in 
the pressure profile can have profound effects on their structure and function. For GPCRs, 
publications on these effects are still comparably rare. However, many studies on other IMPs, 
including mechanosensitive ion channels [41–43] and membrane transporters [44,45], demonstrate 
that the lateral pressure could have important implications for GPCRs. It is by now established that 
GPCR activation includes both large scale structural rearrangements, as well as changes in the 
plasticity of the receptors [46]. It seems therefore tempting to propose that changes in lateral pressure 
of the surrounding bilayer could differentially stabilise certain conformations of the receptors and 
thereby either stimulate or impede GPCR activation. These mechanistic considerations have so far 
been suggested for some mechanosensitive GPCRs [47,48], but might have a much broader 
implication also for other GPCRs in general. 
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3.1.2. Membrane Curvature 
Curvature is a ubiquitous feature of biological membranes. It ranges in its extent from slight 
bending as observed in the plasma membrane to the strongly curved membranes of small cellular 
vesicles. In vivo the curvature of a membrane is often determined by the proteins either associated 
with or embedded in the respective membrane. The membrane associated proteins are in this context 
scaffold proteins such as clathrin, membrane-binding modules such as BAR domains and other 
cytoskeletal components, which can actively bend regions of lipid membranes [49]. IMPs, in contrast, 
can influence membranes from their location within the bilayer as every IMP energetically favours a 
certain membrane curvature for its complementarity to its overall molecular shape. Membrane 
curvature is furthermore strongly intertwined with the lipid composition of the respective bilayer 
leaflets. Lipids as such have distinct three-dimensional shapes, which can be broadly categorised into 
cylindrical, conical and inverted conical, depending on the dimensions of their hydrophobic acyl 
chains relative to the size of their respective head group. A small head group (e.g., phosphatidic acid) 
in combination with bulky, e.g., unsaturated acyl chains, yields a conical shape. A bulky head group 
(e.g., phosphatidylinositol phosphates) in combination with saturated acyl chains or a 
monoacylglycerol scaffold renders the lipid an inverted cone. Membrane lipids eventually localise in 
and stabilise preferentially leaflets of a curvature that are complementary to their own shape [49,50]. 
In their apo state, GPCRs adopt an inverted cone-like shape, which makes them particularly 
complementary to bilayers that show a positive curvature, as for example in dendritic spines or 
fillopodia [46]. Interestingly, agonist binding has been found to relax the intrinsic curvature of 
GPCRs, driving them into a more cylindrical shape [46]. This change in shape is likely explained by 
the large outward movement of TM6 and the simultaneous constriction of the extracellular half of 
the receptors observed in the crystal- and cryo-EM structures of ternary GPCR complexes [51]. The 
change of shape could be an important molecular feature of GPCR desensitisation and internalisation, 
as it facilitates the localisation of activated GPCRs to negatively curved membranes, such as the ones 
of early endosomes (see Figure 2) [52]. Several studies on rhodopsin seem further to support the idea 
that a change in membrane curvature can significantly affect the equilibrium of the different 
conformational states of GPCRs [53,54]. 
3.1.3. GPCRs and the Hydrophobic Mismatch 
The major characteristic of IMPs is their membrane spanning hydrophobic transmembrane 
domains (TMDs). TMDs have a defined hydrophobic thickness (dTMD) that determines their 
interaction with the hydrocarbon core of a membrane. A difference in the thickness between dTMD and 
the hydrocarbon core (dHC) is defined as a hydrophobic mismatch (ΔdTMD-HC). Hydrophobic TM 
segments are in IMPs further often flanked by so-called anchoring residues [55,56]. These help to 
position the tips of the TMDs in the interface region of the lipid bilayer. The most prominent 
anchoring residues are the amphiphilic aromatic amino acids Trp and Tyr [57]. These localise 
favourably in the bilayer interface region, where they can partition into the hydrocarbon core and at 
the same time form hydrogen bonds with lipid carbonyls, as well as π-cation interactions with 
positively charged head group moieties [57,58]. Another class of anchoring residue are the positively 
charged amino acids Lys and Arg. They are often localised within the hydrophobic TM segments 
and, with their long and flexible side chains, “snorkel” into the interface region to form stabilising 
contacts with polar and negatively charged lipid head groups [59,60]. 
A difference in hydrophobic thickness between TMDs and a membrane, as well as an 
unfavourable positioning of anchoring residues, are accompanied with a high energetic cost [61]. 
IMP-membrane systems can minimise that cost in several ways. On the one hand, membrane lipids 
have a certain elasticity in the z dimension and can thus adapt to a hydrophobic mismatch by either 
stretching or compressing the length of their acyl chains [62,63]. On the other hand, IMPs can 
minimise the hydrophobic mismatch by tilting their TMDs relative to the lipid membrane. 
The adaption of IMP structure to a given hydrophobic mismatch has been extensively studied 
for low-complexity model IMPs, such as glycophorin A (GpA). These studies show that TMD tilting 
in response to a hydrophobic mismatch largely preserves inter-TMD interactions (hydrogen bonds 
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and salt bridges), while the overall structure of the IMP is evidently altered [64]. For GPCRs, studies 
on the concrete effects of a hydrophobic mismatch are still sparse. However, experimental and 
computational data suggest that the structure and function of GPCRs can in fact be modulated by the 
hydrophobic mismatch between a receptor and its lipidic environment [65]. 
It remains, however, questionable whether these findings are physiologically relevant for 
GPCRs. While it is known that cellular membranes vary in their hydrophobic thickness [66], their 
complex lipid composition also allows recruitment processes to take place. Lateral diffusion of lipids 
and IMPs can lead to phase separation within the plane of the membrane, where lipids and IMPs of 
similar hydrophobic thickness can cluster together and form nanodomains [67,68]. In the context of 
GPCRs, this has critical implications for the trafficking and localisation of the receptors [63] and is 
furthermore likely to regulate the formation of GPCR oligomers [69,70]. The local concentration of 
certain lipid species in membrane nanodomains may further be an important factor for stoichiometric 
lipid–GPCR interactions (see Section 3.2) [71]. 
Molecular dynamic (MD) simulations have revealed structural and kinetic aspects of lipid 
nanodomains. Recently, all atom MD studies by the groups of Vattulainen and Lyman indicated the 
presence of substructures within the Lo (liquid-ordered) bilayer phase [72–74]. In such studies, the 
slow kinetics of phase separation hampers the ability to observe spontaneous segregation into 
coexisting Lo/Ld (liquid-disordered) domains. Coarse-grained (CG) models, facilitating longer 
modelled durations, have proven invaluable in exploring this aspect. Spontaneous formation of Lo 
and Ld domains in ternary mixtures of cholesterol, saturated and unsaturated lipids show structural 
and dynamic properties closely matching experimental data [75]. Further studies have explored the 
effect of lipid composition on the properties of lipid domains [76–79]. 
Several MD simulation studies commonly using a Martini coarse-grained force field (CGFF) 
were used to explore the oligomerisation tendency of membrane proteins including GPCRs and 
found evidence for self-assembly. Using Martini coarse-grained molecular dynamic (CGMD) 
simulations, the oligomerisation tendency of 16 rhodopsins embedded in lipid bilayers of varying 
thickness was monitored [69]. Maximal dispersion of rhodopsin was found at an intermediate bilayer 
thickness matching the hydrophobic thickness of the receptor, while its propensity to form inter-
protein contacts increased in thinner and thicker bilayers [69]. Mismatch induced oligomerisation can 
be explained by a minimisation of the energetic cost, which decreases as two proteins experiencing 
similar hydrophobic mismatch approach one and other [80]. Spontaneous self-assembly depending 
on the membrane thickness is in agreement with experimental FRET [70] and EM based observations 
[81]. The latter suggests that a certain level of mismatch can be tolerated, as no significant 
oligomerisation of bacteriorhodopsin occurs in PC membranes up to 4 Å thicker or 10 Å thinner than 
the embedded protein [81]. 
3.1.4. Electrostatic Membrane Potentials and GPCR Function 
Biological lipid membranes display complex electric potentials, which can significantly affect 
the function of GPCRs and other IMPs. A standard electric potential of a cellular membrane can be 
described in simple terms as the sum of three distinct potentials [30,82]: 
Ψtot(z) = ∆Ψ(z) + ΨS(z)+ ΨI(z) (1) 
The total electric potential Ψ௧௢௧ in the z dimension of the membrane can be decomposed into 
contributions from a transmembrane potential ΔΨ, a surface potential of the lipid head groups Ψௌ 
and an internal electric potential Ψூ . The resulting total electric potential profile of a cellular 
membrane will be similar to the one depicted in Figure 2. 
The transmembrane potential ∆Ψ is the electric potential difference between the two aqueous 
phases separated by the respective membrane. Nearly all biological membranes show such an electric 
potential difference or are, in other words, polarised. This polarisation can reach considerable 
voltages of up to −90 mV [83]. This corresponds to energies of approximately 8 kJ mol−1 for the transfer 
of a charge across the membrane (cf. Equation (2)). Given the small dimensions of the membrane, this 
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further amounts to enormous electric field strengths and accordingly very strong electric forces in 
the lipid bilayer [84]. 
∆G0’ = ∆Ψ × q × F (2) 
with ∆G0’ being the standard Gibbs free energy for the translocation of a charge q over the membrane, 
ΔΨ the respective transmembrane potential and F the Faraday constant (≈96,485.3 C mol−1). 
In the biological context of GPCRs, it is important to appreciate that strong modulations of ∆Ψ 
(up to ±100 mV) are extensively used by cells for communication and signal propagation [85,86]. 
Ψs is predominantly determined by the head group composition of a lipid bilayer. As biological 
membranes contain a mixture of neutral, zwitterionic and negatively charged head groups, ∆Ψ 
usually constitutes a negative electric potential in the interface region of the bilayer [30,87]. This has 
important implications in the context of in vitro studies of GPCRs. Most membrane mimetics used 
today lack a negative surface potential. This includes commonly used neutral detergents, as well as 
zwitterionic membrane lipids used in lipid nanodiscs or nanoparticles. With the ambition to mimic 
cellular membranes, it is reasonable to include negatively charged head groups in the membrane 
mimetic [88,89]. ΨI comprises the electric potentials of the hydrocarbon core of the lipid membrane. 
ΨI is in this context dominated by the dipole moment of the lipid acyl chains. This dipole moment is 
caused by the electronegativity of the carbonyl moiety that polarises the entire acyl chain of a lipid 
[90,91]. 
These electric potentials have an influence on many membrane properties, such as ion 
permeability or interactions of the membrane with charged solutes. Most importantly, however, the 
electric potentials can actively shape the structure, dynamics and function of IMPs. The field of 
studying these effects on GPCRs is still rather exotic. For other IMPs, including in particular voltage 
gated ion channels, the significant influence of ∆Ψ is a well understood and appreciated phenomenon 
[92,93]. An important starting point for considerations of any influence of electric potentials on 
GPCRs is the discovery that the receptors display defined “gating currents” in electrophysiological 
terms. On a molecular level this means that charged moieties of the receptors can move in the z 
dimension in response to changes in ∆Ψ [94]. Over the course of the past two decades, the activation 
of several GPCRs, including P2YR, all muscarinic acetyl choline receptors (M1-5) and the δ-opioid 
receptor [95–97], was shown to be significantly modulated by ∆Ψ. 
The concrete molecular mechanisms underlying these activity modulations are still subject to 
debate. The explanations range today from the movement of charged GPCR residues to allosteric Na+ 
switches that are triggered by changes in ∆Ψ [94,96]. It is important to note that Ψtot can, of course, 
also influence charged ligands and cytoplasmic coupling partners (CCPs) and thereby modulate the 
apparent activity of GPCRs. 
3.1.5. External Factors Governing Membrane Properties 
The Aqueous Phases Shape Membrane Properties In Vivo and In Vitro 
In order to understand and faithfully mimic lipid membranes, it is important to appreciate that 
their physicochemical properties are critically influenced by the surrounding aqueous compartments. 
Factors, such as pH, ion concentrations or the presence of small amphiphilic molecules in these 
compartments have long been known to modulate, e.g., the phase transitions, the permeability or the 
thickness of lipid bilayers. As outlined in the sections above, these factors have the potential to 
modulate the structure, dynamics and eventually function of GPCRs. Especially in an in vitro context, 
buffer conditions should be carefully assessed therefore with regard to the effects they exert on 
different membrane mimetics. 
pH and ion concentrations are factors that are known to strongly affect lipid bilayers. As 
biological lipid head groups are either neutral, zwitterionic or negatively charged and contain, in 
most cases, a phosphate moiety, cations such as Na+ or Ca2+ interact strongly with the interface region 
of lipid bilayers. As counter ions for negatively charged head group moieties, they generally 
contribute to the stability of the lipid bilayer. At the same time, cation interactions induce a decrease 
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in the lateral pressure and fluidity of lipid membranes [62]. The coordination of cations by the 
membrane lipids further leads to an increase in acyl chain order, which causes a thickening of the 
lipid bilayer and a corresponding loss of elasticity in the z dimension [98,99]. Interestingly, similar 
effects on the membrane properties are induced by low pH values. It is currently unclear whether 
these effects are caused by protonation of the lipid head groups [62] or the increased concentration 
of hydronium ions [100]. It has been shown, however, that a low pH increases the melting 
temperature and the permeability of lipid membranes and modulates their mechanical properties 
[101]. 
Small amphiphilic molecules can partition into the hydrocarbon core of the membrane and can 
thereby modulate membrane properties. Those molecules include general anaesthetics, such as 
isoflurane or N2O [62], as well as common signalling molecules, such as serotonin [102,103]. Small 
amphiphilic molecules have been shown to lower, e.g., the melting temperature and to relieve lateral 
pressure in lipid bilayers [62,104]. These effects can in turn influence GPCRs. For in vitro studies on 
GPCRs, this consideration has several implications. On the one hand, small amphiphilic molecules 
can be used to selectively manipulate properties in membrane mimetics. For example, TFE has been 
added to rule out lateral pressure effects [3]. On the other hand, it implies that GPCR ligands can also 
have membrane mediated effects, especially at the saturating concentrations of >1 mM often used in 
experiments [105]. 
Temperature 
A key factor shaping lipid bilayer properties is temperature. The temperature effectively 
determines the energy of a membrane system, which is decisive for many central parameters of a 
lipid bilayer, ranging from acyl chain order, over lateral fluidity to general phase transitions. In 
biological membranes lipids are usually in a fluid liquid-disordered (Ld) or liquid-ordered phase (Lo), 
in which they are able to diffuse in the lateral dimension [106]. The transition temperature to a gel-
like solid phase is in living cells actively adjusted to remain usually approximately 10–15 °C below 
the ambient temperature. This is often achieved by an increased incorporation of unsaturated and 
shorter acyl chains into the membrane [107]. 
In vitro, however, a maximum of a few lipid species can be used in fixed mixtures. This can 
result in membrane mimetics with extreme properties. This becomes particularly pronounced with 
regard to their melting regimes, as commonly used membrane lipids have melting temperatures 
from, e.g., −18 °C for DOPG to 60 °C for DSPC. This has important implications for the work on 
GPCRs, since the difference between lipid-melting and ambient temperature can dictate whether the 
lipid bilayer surrounding the GPCR being studied is in a fluid Ld/Lo or a solid phase [62]. The 
respective phase state can further affect other membrane properties, such as the thickness or the 
elasticity of the lipid bilayer [62]. 
3.2. Specific Lipid–GPCR Interactions 
With their helical transmembrane core embedded in the phospholipid bilayer, GPCRs are 
susceptible to the general non-specific properties of the membrane bilayer as described in the 
previous sections. It is important, however, to understand the impact specific or stoichiometric lipid 
interactions have on receptor structure and function [108–111]. Next to, and likely associated with, 
directly modulating the conformational landscape sampled by a receptor membrane, bound lipids 
have been suggested also to influence ternary interactions between GPCRs and G proteins [112,113]. 
One of the earliest indicators for a role of specific lipid interactions was the adverse effects 
delipidation had on the function of the β2 adrenergic receptor [114]. Since then, individual lipid 
interactions with GPCRs, as well as less specific and general membrane effects have been implicated 
in disease progression during ageing [115]. These observations emphasize the need to understand 
the role of lipids for function and organisation of GPCRs under normal and pathological conditions. 
Specific lipid interactions could be defined based on the concept of “non-annular” sites of 
individual lipids in membrane proteins [116,117]. Non-annular lipids are not effectively displaced by 
competition with annular lipids, hence they are characterised by the lack of accessibility to the bulk 
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lipid pool [118]. The molecular descriptors leading to specific lipid interactions overall are still little 
understood but are increasingly becoming the subject of experimental and computational studies. 
Over recent years our understanding of activation mechanism of GPCRs and their dynamic 
behaviour has been significantly enhanced by all atom MD simulations of these receptors with some 
focus on β2AR as a model protein [119–122]. MD simulations are now helping to describe, at a 
molecular level, how lipidic modulators such as cholesterol exert their influence. 
3.2.1. Cholesterol 
As far as lipid interactions with GPCRs are concerned, studies involving cholesterol are the most 
abundant. Cholesterol is a modified steroid lipid biosynthesized by all animal cells. As an essential 
structural component of membranes, it is known to modulate membrane fluidity in relation to 
changes in the environmental temperature. A short hydroxyl moiety of cholesterol forms the head 
group of the molecule interacting with the polar phase, whilst planar steroid rings are embedded in 
the membrane. Cholesterol interactions with proteins have been explored extensively by a range of 
methods including X-ray crystallography, cryo-EM, NMR spectroscopy and MD simulations [123–
125]. Lipid rafts present in cell membranes consist of nanoscale domains that impact on structure and 
function of the proteins embedded within them [126,127]. Changes in the surrounding lipid 
composition influences GPCRs, which may be triggered by cholesterol promoting the dynamic 
assembly of such nanoscale membrane domains [74]. Cholesterol modulates the physical properties 
of membranes by increasing the bilayer thickness and order while slowing the dynamics [79]. As 
discussed earlier, changes in such general characteristics can influence the dynamic nature of a 
membrane protein [128]. A variety of experimental studies suggest that cholesterol affects the 
conformation and function of many GPCRs [108,123,129,130]. However, while cholesterol is a 
significant component of biological membranes in reference to changes in GPCR function and 
supramolecular organisation, its mechanism of action is still a matter of debate [131]. 
Based on the extensive work from the Chattopadhyay lab, Sengupta and co-workers used 
Martini coarse-grained molecular dynamic (CGMD) simulations to study the interaction of 
cholesterol with GPCRs and rationalize its effects on their oligomerisation [132]. The interaction 
pattern of cholesterol with a serotonin receptor (5-HT1A) was characterised for a single receptor 
molecule embedded into a POPC bilayer containing variable amounts of cholesterol [133]. Overall, 
cholesterol molecules explored most of the receptor surface during the simulations but spent a 
significant amount of time bound to specific locations. One of these locations corresponded to one of 
the consensus cholesterol-binding motifs (CRAC) on transmembrane helix 5 (TM5) [134]. Further 
work from the Sengupta group simulating the self-assembly behaviour of β2AR in a POPC bilayer 
showed that varying the amount of cholesterol affected the dimerisation interface of the receptors 
[135]. Without cholesterol, β2ARs almost exclusively interact via TM4/5, while with increasing 
amounts of cholesterol, β2AR assembled also via TM1/2 contacts. At 50% cholesterol, β2AR switched 
to an almost exclusive mode of assembly using TM1/2 in a symmetric interface. Occupancy analysis 
suggested that higher levels of cholesterol resulted in blocking a protein–protein interaction site 
located at the centre of TM4. This site matched the position of a cholesterol molecule found in a crystal 
structure [136,137]. 
Cholesterol is found to be necessary in crystallising β2AR [137], and like its soluble analogue 
cholesteryl hemisuccinate (CHS), it has been shown to improve β2AR stability [138]. Crystal 
structures of β2AR showed further that cholesterol binding changed the structural properties of the 
receptor [136,138]. Other techniques have identified cholesterol binding sites. Two classes of 
cholesterol binding sites for β2AR were found by NMR spectroscopy [139], while MD simulation 
studies indicated direct interactions between cholesterol and GPCRs, including A2AAR and β2AR 
[117,135,140,141]. Concerning GPCRs overall, at least seven distinct cholesterol binding sites have 
been observed in crystal structures of different receptors [136,137,142–147] (Table 1 and Figure 3). 
MD simulations also revealed seven potential cholesterol binding sites on the surface of β2AR. Out 
of these, three match the ones observed in crystal structures [140]. A different MD study of the same 
receptor identified three specific high affinity cholesterol interaction sites, two on the intracellular 
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side at the cleft of helices TM5-TM6 and TM1-TM4 with one site on the extracellular side in the TM5-
TM6-ECL3-TM7 region [128].The latter two sites agreeing with crystal structures. Further it became 
obvious that the conformational distribution of β2AR drastically altered as the concentration of 
cholesterol increased to ~10 mol% [136,137,143,148]. The TM1-TM4 cleft showed binding of two 
cholesterol molecules as predicted for 44% of human class A receptors characterised by the 
cholesterol consensus motif (CCM) [136]. Mechanistic insight was possibly observed as binding of 
cholesterol molecules in the TM5-TM6-ECL3-TM7 cleft regulated TM5/TM6 helix movements 
making it a potential allosteric modulator of receptor activity. 
Table 1. Lipid binding sites in GPCR crystal structures for cholesterol (C), cholesteryl hemisuccinate 
(CHS) and palmitate (P). The number of bound lipids and the binding interfaces are indicated (IC, 
intracellular cleft; EC, extracellular cleft; ECL, extracellular loop; ICL, intracellular loop). The locations 
of the individual binding sites 1–7 are shown in Figure 3. 
Site GPCR PDB IDs 
Number of 
Bound Lipids Binding Interface 
Crystal Contacts (C) or 
Dimer Interface (D) 
1 β2AR 2RH1, 
3D4S 2 × C IC; helices I–IV C 
1 β1AR 2Y00 1 × CHS IC; helices II–IV, ICL1 C 
1 P2Y12 4PXZ 1 × C IC; helices II–IV, ICL1 C 
2 β2AR 2RH1 1 × P IC; helices I, VIII, palmitate D 
2 5-HT2B 4IB4 1 × P IC; helices I, VIII, palmitate D 
3 β1AR 2Y00 1 × CHS IC; helices III–V C 
3 
P2Y12 
GABAB 
4NTJ 
6WIV 
1 × C 
2 × C 
IC; helices III–V 
IC; helices III–V 
C 
D 
4 A2AAR 4EIY 1 × C EC; helices V–VI C 
4 β1AR 2Y00 1 × CHS EC; helix V C 
5 
A2AAR 
μ-OR 
4EIY 
4DKL 11 × C 
EC; helices VI–VII, ECL3 
EC; helices VI–VII, ECL3 
 
6 P2Y12 4NTJ 1 × C EC; helices VII, I  
7 A2AAR 4EIY 1 × C EC; helices II–III, ECL1 C 
7 mGlu1 4OR2 3 × C EC; N-term, helices I–III, ECL1 D 
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Figure 3. Cartoon overlay of GPCR crystal structures showing different cholesterol binding sites 
found (PDB accession codes: 2RH1, 3D4S, 4PXZ, 4IB1, 4NTJ, 6WIV, 4EIY, 4DKL, and 4OR2). 
Structures are aligned with β1AR (PDB accession code: 2Y00). The locations of the lipid binding sites 
are numbered according to Table 1. Cholesterol and cholesteryl hemisuccinate molecules are shown 
in red (binding sites 1–7), and the palmitoyl lipids are displayed in orange (binding site 2). 
3.2.2. Anionic Lipids 
Non-annular lipid binding sites in GPCRs are known to show high selectivity for anionic over 
zwitterionic lipids. It has been proposed that a change in the type of non-annular lipid alters the 
packing at protein–protein and/or protein–lipid interfaces modulating the protein activity [149]. The 
overall strength of specific protein–lipid interactions depends on the net charge of the lipid head 
groups that can either covalently link to the protein, form specific hydrogen bonds, be involved in 
ion-mediated salt bridges or take part in electrostatic interactions. The charged protein and lipid 
components affect membrane partitioning and the translocation thermodynamics [150]. 
In GPCRs, anionic lipids have been reported to perturb ionic lock formation between the 
cytoplasmic moieties of TM3 and TM6 and promote receptor activation. MD simulation studies of 
β2AR, showed that a phospholipid from the cytosolic leaflet appeared to insert between receptor 
helices TM6 and TM7 forming a salt bridge with the guanidino moiety of residue R3.50 (Ballesteros–
Weinstein numbering) [151] when the receptor was in an active state [152]. The salt bridge acts as a 
“door stopper” in the activated receptor as it awaits favourable interaction with downstream 
signalling proteins. Anionic lipids enhance the stability of the receptor active state and increase its 
lifetime by three-fold, but it is unclear whether this is solely due to the R3.50 interaction with lipids. 
Increased agonist binding and activation in the presence of phosphatidylglycerol was 
demonstrated for nanodisc reconstituted β2AR [112]. The study went on to show that the increase in 
activation could also be obtained in the absence of a bilayer while using detergent-solubilized 
negatively charged lipids, suggesting that the latter were acting as specific allosteric modulators. In 
agreement with these results, exploring endogenous lipid–receptor interactions for the three class A 
receptors (β1AR, A2AAR and NTR1) high-resolution native mass spectrometry (MS) revealed that PIP2 
stabilises the G protein-bound active state of the receptors and enhances selectivity of coupling to G 
proteins [31]. The observations were also accompanied by an increase in GTPase activity. Using 
CGMD simulations, four conserved PIP2 binding sites were identified, involving TM1/TM2/TM4, 
TM3/ICL2/TM4, TM3/TM5 and TM6/TM7. 
To characterise the interactions of A2AAR with polyanionic phospholipids and glycolipids, 
CGMD simulations were performed for this receptor in an active and inactive state, or an active state 
bound to mini-Gs. All modelled structures were embedded in an in vivo-mimetic membrane [141]. 
The polyanionic phosphorylated inositol head group of PIP2 was found to interact with several basic 
arginine and lysine residues, with lipid binding concentrating on nine binding sites. While the 
binding locations for PIP2 and GM3 were found to partially overlap, the binding probabilities clearly 
depended on the activation state of the receptor, in agreement with the earlier studies by Dawaliby 
et al. [112]. Potential of mean force (PMF) calculations of the free energy landscape for A2AAR/PIP2 
and A2AAR/mini-Gs interactions suggested a dual role for PIP2, promoting both activation of the 
receptor as well as its association with mini-GS. In addition, the study found also that increases in the 
flexibility of ECL2 as seen in the active state might be related to shortened interaction times of GM3 
with ECL2 proximal regions. This would facilitate ligand access to and from the orthosteric binding 
site, accordingly, influencing the kinetics of ligand binding [141]. 
3.2.3. Sphingolipids 
Sphingolipids constitute 10–20% of total membrane lipids in eukaryotic cells and are known to 
contribute to lipid segregation into microdomains [153]. Sphingomyelin as the main component is 
regarded as a reservoir for second messenger molecules such as ceramide and sphingosine-1-
phosphate [154]. Specific binding of receptor agonists to the human serotonin 1A receptor was 
markedly reduced when sphingomyelin in the membrane surrounding the receptor was converted 
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to ceramide by sphingomyelinase with no significant perturbation to the membrane order [155]. This 
effect on agonist binding was found to be reversible on replenishment of sphingolipids [156]. 
Prompted by the observed sensitivity of serotonin 1A towards sphingolipids, amino acid sequence 
analysis led to the proposal of a putative sphingolipid binding domain (SBD) [157], which in parts 
overlaps with the cholesterol CRAC motif on TM5 [158]. The presence of a similar motif was 
predicted for the cholecystokinin and the oxytocin receptors, while two SBD motifs were predicted 
for the secretin receptor [159]. Despite an extensive characterisation of the signalling features the role 
of sphingolipids in modulating GPCR function remains little understood. 
3.2.4. Unsaturated Acyl Chains 
As described in Section 3.1, the type of lipid acyl chains influences membrane fluidity, flexibility 
and lateral pressure. However, they also play a key role in specific interactions with the embedded 
receptors [160,161]. Unsaturated lipids contain fatty acid side chains with one or more double bonds 
in their structures, such as palmitoleic acid, oleic acid, myristoleic acid, linoleic acid and arachidonic 
acid. Eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) the most abundant ω-3 fatty 
acid in human brains [162] are among the very-long-chain polyunsaturated fatty acids obtained from 
diet or metabolised in small amounts from linoleic acid [161,163,164]. At present, studies on specific 
effects of unsaturated lipids in the context of GPCR function are still sparse and the effects of 
unsaturated acyl chains on the receptor conformation may vary for different receptor classes, as many 
of the lipid-facing residues in the TM regions are little conserved. 
For rhodopsin, it was observed using UV–visible absorption spectroscopy that DHA chains 
facilitated a transition from the light-activated meta-rhodopsin I form to the G protein-binding 
intermediate meta-rhodopsin II. This transition is characterised by inactive and active conformations 
of the NPxxY motif on TM7 [165]. 
A recent NMR study of A2AAR embedded in lipid nanodiscs showed that DHA chains increased 
G protein activation [166]. A2AAR bound to the full agonist was found in an equilibrium involving 
multiple active conformations of TM7. DHA was observed to accelerate conformational exchange 
and to shift the equilibrium towards a conformation displaying a large clockwise rotation of TM6. 
The latter was postulated to be preferable for G protein activation. 
Combining all atom and CGMD simulations with free energy calculations, it was found that 
DHA-containing hybrid lipid enhances A2AAR partitioning into the Lo phase while in the absence of 
DHA the receptor partitioning into the Ld phase is energetically favoured [167]. It is believed that 
this tendency relates to the kinked topology of the A2AAR that favours the interaction with DHA and 
other unsaturated lipids as the first lipid shell surrounding the receptor. Analogous studies with the 
dopamine D2 receptor [168] and a lipidomics-style analysis of the brain-associated glucose 
transporter (GLUT1) [169] whose function is dependent on poly-unsaturated fatty acids point 
towards similar partitioning into the Lo phase in the presence of DHA/DHA-containing hybrid lipids. 
Although GLUT1 is not a GPCR its similar response to DHA-dependent phase partitioning is 
suspected to relate to a similarly rugged shape of its transmembrane helical domains. In contrast, 
comparative CGMD simulations performed on ErbB1, VDAC-1 and a GpA dimer did not show any 
efficient solvation of these proteins [167]. This supports a role for DHA in selective raft partitioning, 
leading to the modulation of protein–protein or protein–lipid interactions. As DHA favours the 
solvation of GPCRs it is tempting to speculate that a reduced DHA content would change the 
signalling properties of receptors through changes in their partitioning. 
4. Membrane Mimetic Systems for Structural and Functional Studies 
4.1. Detergents 
The first detergents to be used in biochemical studies were naturally occurring bile salts [170] 
and saponins [171]. However, since the advent of synthetic detergents, a vast array of different 
surfactants have become available [172]. All detergents follow the same broad architecture, having 
both hydrophobic tails and hydrophilic head group regions. This amphipathic nature gives rise to 
Molecules 2020, 25, 4729 14 of 37 
 
their ability, above the critical micelle concentration (CMC), to self-assemble in an aqueous 
environment [173]. This thermodynamically driven process results in detergent micelles organised 
with the hydrophilic moieties facing outward to interact with the surrounding water whilst the 
hydrophobic regions pack together in the centre [174]. 
The solubilisation of proteins from a lipid membrane environment begins with detergent 
molecules partitioning into the membrane; this is followed by cooperative binding to the protein 
leading to micelle formation around the protein separating it from the bulk of the lipid phase [175]. 
Whilst separation of the target protein from the lipid phase is the main goal, as it allows the protein 
to be isolated and studied, this can lead to excessive delipidation which can have adverse 
consequences particularly in the case of GPCRs. As discussed above, the requirement for protein–
lipid interactions is becoming increasingly apparent for GPCRs and stripping lipids away from the 
protein can cause destabilisation and inactivation [176]. This destabilisation can be circumvented by 
the introduction of thermostabilising mutations. However, these can modify protein dynamics and 
therefore the constitutive activity of a receptor when compared with its wildtype form [177]. 
Therefore, choice of a mild detergent that has been shown to allow the retention of key lipid 
interactions and which only binds to the transmembrane region of a given protein is key for 
successful studies [178]. 
The huge range of existing detergents vary greatly in their biophysical properties. However, 
they can be classified into three major families: ionic detergents such as SDS or deoxycholate carry a 
net charge and are often strong denaturants; zwitterionic detergents such as LDAO or CHAPS which 
are not commonly used for GPCRs; non-ionic detergents which are generally milder and have 
hydrophilic groups most commonly consisting of glucosides or PEG [179]. Due to their milder nature, 
non-ionic detergents and more specifically alkyl glucosides are most commonly used in the isolation 
of intact GPCRs for biochemical studies. Generally, there is no one detergent appropriate for all 
receptors, requiring screening to find a suitable candidate. Indeed, taking a modular approach a 
recent publication demonstrated that varying tail and head groups can greatly affect the functionality 
and lipid retention of preparations of NTR1 [180]. Within the family of alkyl glucosides, it seems that 
varieties with branched alky chains, in particular LMNG, increase the stability of isolated receptors 
[181,182]. MD simulations comparing LMNG to DDM (a non-branched alkyl glucoside) showed 
LMNG displayed increased density of alkyl chains covering the hydrophobic region of the receptor 
and higher levels of hydrogen bonding between detergent head groups. These interactions led to 
reduced mobility of the receptor [183]. Reduced mobility may, however, be deleterious for studying 
conformational changes in receptors; investigations by NMR of the β2AR in either DDM or LMNG 
showed the latter to slow ligand induced conformational exchange, attributed to the lower off-rates 
of this detergent [184]. 
The majority of studies on isolated membrane proteins are still carried out in a detergent system; 
GPCR research is no exception (Table 2) where well-established protocols have greatly simplified 
membrane extraction. The vast majority of GPCR structures deposited in the PDB have been obtained 
for receptors in detergent micelles [185]. Further, the proven ability to make homogeneous particles 
with sizes (Figure 4) that relate to sufficiently rapid rotational tumbling means detergents have been 
a favoured system for solution NMR studies. This has facilitated the extensive exploration of the 
conformational exchange dynamics of isolated receptors and revealed GPCRs as populating multiple 
equilibria between different states (Figure 1B). Such studies have been key to understanding 
phenomena such as allosteric coupling, ligand efficacy, partial agonism and signalling bias [186,187]. 
Interactions with specific lipid bilayer components can also be probed by forming mixed micelles of 
detergent and lipid at a controlled ratio. This has been used to demonstrate that the cholesterol 
derivative CHS stabilised the A2AAR receptor [188]. Indeed, CHS has become a common additive to 
detergent solubilised receptors in many NMR studies (Table 2), enabling longer experiment times 
[143,189,190]. In other studies mild detergents such as LMNG and DDM that reduce the delipidation 
of GPCRs allowed interactions of receptors with endogenous lipids to be elucidated. For example, 
mass spectrometry combined with activation assays demonstrated the specific binding of PIP2 and 
its relevance in purified class A receptors coupling to Gα [31].  
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Table 2. Studies of GPCR conformational dynamics using solution-state NMR in conjunction with various membrane mimetics. 
Receptor Expression System Membrane Mimetic Labelling NMR Experiment Reference 
β2AR Sf9 DDM 13CH3-Lys (reductive methylation) STD-filtered 1H,13C HMQC; 1H,13C HSQC [191] 
β2AR Sf9 DDM/CHS 19F-TET 19F; 1D [143] 
β2AR expressSF+ DDM 13CH3-Met or α,β,β-2H3,13CH3-Met 1H,13C-HMQC [192] 
β2AR Sf9 DDM/CHS or LMNG 19F-BTFA 19F; 1D, T1, T2 [184] 
β2AR Sf9 LMNG 19F-BTFA 19F; 1D, T1, T2 [193] 
β2AR Sf9 DDM 13CH3-Met 1H,13C HSQC [194] 
β2AR Sf9 DDM/CHS 19F-TET 19F; 1D, 2D EXSY [195] 
β2AR expressSF+ POPC/POPG nanodiscs b2AR [2H-9AA, abg 2H,13CH3-Met] 1H,13C-HMQC; 1H,15N [196] 
β2AR Sf9 LMNG 19F-BTFA 19F; 1D, CPMG, STD [197] 
mOR Sf9 LMNG/CHS 2H-8AA, ab-2H-13CH3-Met 1H,13C-HMQC [198] 
mOR Sf9 LMNG/CHS 13CH3-Lys (reductive methylation) 1H,13C-HMQC [189] 
b1AR Sf9 DDM u-2H,15N 1H,15N TROSY [199] 
b1AR High five DM 15N-Val 1H,15N HSQC [200] 
A2AAR P. pastoris LMNG 19F-BTFMA 19F; 1D, STD [201] 
BLT2 E. coli DMPC/CHS nanodiscs U-2H, 13CH3-δ1-Ile, 13CH3-ϵ-Met 1H,13C-HMQC [123] 
b1AR Sf9 or Sf21 LMNG 13CH3-Met 1H,13C-HMQC [6] 
A2AAR P. pastoris DDM 13CH3 Ile d1/2H 1H,13C HMQC, 3Q-relaxation [202] 
NTR1 E. coli DMPC/DMPC nanodiscs U-2H, 13CH3-δ1-Ile,13CH3-ϵ-Met] 1H,13C-HMQC [203] 
A2AAR P. pastoris LMNG/CHS U-15N, 70% 2H 1H,15N TROSY [204] 
A2AAR P. pastoris LMNG/CHS U-15N, 70% 2H 1H,15N TROSY [190] 
CCR5 Sf9 DDM U-2H,15N 1H,15N TROSY [205] 
NTR1 E. coli DDM 13CH3-Met 1H,13C-HMQC [206] 
β2AR b2AR: expressSF+ 
C-terminal tail: E.coli 
POPC/POPG nanodiscs 
b2AR [2H-9AA, abg2H,13CH3-Met] C-tail: 
U-[2H, 13C, 15N] or 13CH3 Thr g2 and Ile d1 
1H,13C-HMQC; 1H,15N 
HSQC; cross-saturation 
[207] 
β2AR expressSF+ β-DDM or POPC/POPG nanodiscs α-2H,
13CH3-Ala; αβγ-2H,13CH3-Met;  
13C-Ile; 13C-Leu; 13C-Thr; <80% 2H 
1H,13C HSQC; 1H, 13C TROSY [208] 
A2AAR P. pastoris LMNG 19F-BTFMA; metal ions 19F, 23Na+, 25Mg+; 1D, CPMG [209] 
A2AAR Sf9 DDM/CHS 19F-TET (in membrane labelling) 19F; 1D, 2D EXSY [210] 
M2R  Sf9 LMNG/CHS  13CH3-ε-Met 1H,13C HSQC [211] 
β2AR Sf9 LMNG/CHS or POPC/POPG nanodiscs 19F-BTFMA 19F; 1D [212] 
β1AR Sf9 DM 15N-Val 1H,15N TROSY [213] 
β2AR Sf9 LMNG [2,3,3-2 H, 15N]-Leu, MSTL 1H,15N TROSY, PRE [3] 
β1AR Sf9 LMNG 19F-TET 19F; 1D, CPMG, STD [7] 
A2AR P. pastoris nanodiscs (POPC/POPG and/or SAPC 
or SDPC) 
α,β,β-2H,13CH3] Met, u-2H 
1H,13C-HMQC; 1H 1D; 31P 1D; solution 
PRE 
[166] 
α1AR  E. coli DDM/CHS 13CH3-ϵ-Met 1H,13C-HMQC [214] 
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Ultimately, however, a detergent micelle offers a poor mimic of the lipid bilayer. Detergent 
molecules have hydrophobic tails that are short and highly mobile as compared to the alkyl tails of 
lipids, this means the isolated protein can dictate the thickness and shape of the hydrophobic phase, 
allowing non-physiological conformations to be adopted [215]. The hydrophobic packing in micelles 
is weak compared to a membrane allowing increased water penetration which has been suggested to 
destabilise receptors [216]. Further, the relatively large ratio of hydrophilic to hydrophobic moieties 
seen in detergents results in much broader dielectric gradients than observed in a membrane [215]. 
Furthermore, detergents can destabilise isolated globular proteins reducing the likelihood for GPCRs 
to be studied in the presence of their native binding partners. Although detergents will likely remain 
a vital tool for GPCR research, the use of mimetics more faithful to native conditions will no doubt 
prove necessary for probing receptor structure and function, whilst facilitating the move away from 
the need for thermostabilising mutations. 
 
Figure 4. Cartoon representation of frequently used membrane mimetics with an embedded GPCR. 
With the exception of the Liposome (G), the individual mimetic systems are displayed to scale (A–F). 
For each system, approximate size ranges are indicated below the individual cartoons. For the non-
bilayer-forming mimetics such as detergent micelles (A) and amphipols (B), size ranges are based on 
the incorporation of a class A GPCR in LMNG or DDM [216,217], or the A8-35 amphipol [218,219]. 
The structures for saposin A (C), MSPD1 (D) and tβ1AR (A–G) were modified from PDB accession 
codes: 4DDJ, 6XBD, 4BVN, respectively. 
4.2. Amphipols 
Amphipathic polymers, or amphipols, were developed in the 1990s by Popot and co-workers 
[220] as an alternative to detergents. There is a growing family of amphipols but all have a 
hydrophilic backbone, commonly polyacrylate, with various hydrophobic side chains [221]. There 
are very few examples of proteins being directly extracted from native membranes by amphipols and 
general procedures require detergent solubilised protein first, the detergent is then exchanged for the 
chosen amphipol [222]. In fact, amphipols are able to refold protein that has been solubilised by 
denaturing ionic detergents resulting in stable protein. A number of human GPCRs treated in this 
way have been shown to maintain ligand binding competency, for example the growth hormone 
secretagogue receptor (GHSR), CB1 cannabinoid and 5-HT4 serotonin receptors [223,224]. 
Amphipols have very high affinity for the hydrophobic transmembrane regions of proteins and 
form a well-defined structure around the target protein with bound lipids possibly left intact; 
however, they do not feature a bulk lipid phase [225]. The relatively high affinity for hydrophobic 
regions of protein means that only low concentrations of amphipols are required with very little left 
free in solution. It is thought that the lack of free amphipols in samples prevents them from, unlike 
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detergent micelles, acting as a hydrophobic sink for non-covalently bound molecules such as lipids. 
Due to the lack of exchange between soluble particles, amphipols are significantly less destabilising 
than detergents [226]. However, in terms of physiological representation of a membrane bilayer, 
amphipols have little advantage above detergents [222], lacking for example membrane curvature or 
the electrostatic effects of phospholipids. Further, the lack of exchange of lipids, whilst it may be 
stabilising, complicates the study of specific effects of exogenous lipids. Furthermore, it was observed 
in structures of the TRPV2 ion channel that amphipols constricted the overall structure preventing 
conformational changes in the transmembrane domain [227]. This suggests that the use of this 
membrane mimetic may interfere in the study of membrane protein dynamics. 
As alluded to, many reports suggest that amphipols are highly stabilising for membrane proteins 
including GPCRs [228]. Coupled with a modest size increase, this makes them a promising tool for 
solution-state NMR (Figure 4) [229]. Detailed structural characterisation of the lipidic ligand 
leukotriene B4 (LTB4) by NMR showed it to adopt a constrained hook shaped conformation when 
bound to the BLT2 receptor. This was facilitated by the isolation of receptor in partially deuterated 
amphipols [230]. Recently, ligand selectivity was examined by comparing the binding of LTB4 and 
agonist 12-HHT to the same receptor in perdeuterated amphipols [231]. While structural information 
on various 7TM receptors, such as bacteriorhodopsin and melanocortin-2 and -4, has been reported 
in solution [232,233], it is not known whether these investigations using amphipols have progressed 
beyond a proof of principle. Amphipols have also proved useful in other biophysical studies of 
GPCRs. V2 vasopressin receptor isolated into amphipols was shown to activate G protein, and 
conformational changes consistent with biased agonism were observed using TR-FRET and 
tryptophan fluorescence [219]. A key positive aspect of amphipols is that they are open to chemical 
modification; affinity tags can be introduced allowing for receptor–amphipol complexes to be 
immobilised, facilitating ligand-screening techniques as trailed with the ghrelin receptor [234]. 
4.3. Bicelles 
Bicelles are discoidal structures composed of long-chain phospholipids, most commonly DMPC, 
and a detergent, typically CHAPSO or DHPC (a detergent-like short-chain phospholipid). When 
prepared, provided that the phospholipid to detergent ratio (q value) is high enough, the components 
arrange such that a planar phospholipid bilayer surrounded by a rim of detergent molecules is 
formed [235]. Protein reconstitution can be carried out either by adding protein solubilised in 
detergent to phospholipid so that the desired q value is reached, or by solubilising pre-reconstituted 
proteoliposomes [236]. 
For a given lipid and detergent pair, the q value dictates the eventual size (Figure 4) and 
morphology of the bicelle. This means that by altering q, the suitability of this system can be adjusted 
for a range of biophysical techniques. For example, DMPC-DHPC bicelles prepared with q values > 
2.3 will align with a magnetic field and can be used in oriented-sample solid-state NMR in order to 
establish 15N-labelled amide bond orientations and the TM helix angle of the incorporated proteins 
relative to the bilayer normal [237,238], whilst q values ≤ 0.7 allow bicelles to be sufficiently small for 
solution-state NMR to be carried out [239]. 
However, the q value also dictates how well the bicelle might represent a true bilayer 
environment. Looking at backbone amide signals of the Fas TM domain in conjunction with solvent 
paramagnetic relaxation enhancement (PRE), it was found that q values < 0.5 caused transmembrane 
residues to be more solvent exposed, suggesting significant hydrophobic mismatch [240]. Other 
researchers showed that, in terms of morphology and phase behaviour, bicelles with q values < 1 
deviated from true bilayer systems, whilst they essentially represented mixed micelles with no spatial 
separation between surfactant and phospholipid at q < 0.5 [241]. Contrastingly, 31P NMR has been 
employed to show that DMPC and DHPC head groups were well segregated even at q values below 
0.5 [242]. Also, others produced data suggesting that low q bicelles are discoidal and as such represent 
a bilayer patch [239] and that this behaviour was consistent over a broad range of phospholipid 
concentrations (50–300 mM) [243]. Therefore, it remains unclear whether a lipid:detergent “sweet 
spot” can be achieved when using bicelles as membrane mimetics in solution NMR. Problems can 
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also arise as depending on the CMC value of the detergent employed to form bicelles, the 
concentration of monomeric detergent can be substantial in solution and interfere with the study of 
globular proteins such as GPCR binding partners or the extramembranous regions of a receptor. 
However, bicelles do have the advantage of having a highly tuneable composition. This can 
allow solution and solid-state NMR to be used in a complementary way with only minimal changes 
to sample preparation. This is demonstrated for the Y2 receptor which was refolded from SDS 
purified samples into bicelles of low or high q [244]. Furthermore, whilst the canonical bicelle system 
is formed of DHPC and DMPC, other mixes can be used. Researchers have made bicelle-like 
preparations using DDM and CHS that stabilised the ORL-1 receptor [245]. The effect of different 
lipid acyl tails (DMPC vs. POPC) on GHS receptor dynamics was examined in bicelles by MAS solid-
state NMR [246]. Further, bicelles rich in sphingolipids and cholesterol were recently shown to form 
a true bilayer even at low q (>0.25) [247], indicating that the use of bicelles in solution-state NMR-
based GPCR studies may just be a matter of further screening for optimal bicelle components. Even 
if doubts of bilayer “likeness” might be an issue for some preparations, bicelles do appear to perform 
better when examining GPCRs by hydrogen deuterium exchange (HDX). Better sequence coverage 
and more peptide redundancy were observed for β2AR, μOR and PAR1 in bicelles compared to DDM 
detergent micelles, leading to higher-quality HDX data [248]. 
4.4. Liposomes 
Liposomes are vesicular structures consisting of a lipid bilayer enclosing an aqueous space. They 
have been a long-standing system for the study of membrane proteins and membrane dynamics 
[249,250]. Structures with multiple concentric bilayers will form spontaneously upon the suspension 
of a dried phospholipid film in an aqueous buffer; these are termed multilamellar vesicles (MLVs). 
However, MLVs are generally of little use for biophysical studies, as they have an onion-like structure 
with high heterogeneity [251]. Therefore, typically, preparations of MLVs are treated, for example, 
by extrusion or sonication in order to yield uni-lamellar vesicles (ULVs) of a more uniform size [252]. 
The ultimate size distribution of the ULVs depends on the method of formation and the phospholipid 
composition used and can range from small uni-lamellar vesicles (SUVs, 20–100 nm) to large uni-
lamellar vesicles (LUVs, 100–1000 nm) and giant uni-lamellar vesicles (GUVs, >1000 nm) [253]. Even 
within classical preparations of ULVs, there can be heterogeneity and efforts have been made to 
generate liposomes of highly controlled monodisperse sizes. To this end, researchers developed a 
DNA templating technique allowing the formation of liposomes of a desired size with nanometre 
precision in 2016 [254]. The reconstitution of proteins within the liposome bilayer typically proceeds 
by partially solubilising pre-formed ULVs with detergent, adding detergent solubilised protein and 
removing the detergent with bio-beads or dialysis to reform an intact bilayer containing the 
embedded protein. This has facilitated the study of a huge array of membrane proteins, including 
GPCRs in a controlled membrane environment [255–258]. 
Compared with all the membrane mimetic systems explored in this review liposomes offer 
several unique advantages. First, the large size of liposomes allows for multi component systems 
(proteins, ligands and substrates) to be reconstituted [259]. Furthermore, the aqueous lumen can 
encapsulate soluble components allowing entire GPCR signalling pathways to be reconstituted, for 
example the M1 muscarinic receptor along with Gq/11βγ and phospholipase C in liposomes were 
induced to produce inositol triphosphate upon exposure of carbachol [260]. Secondly, due to the 
compartmentalisation of an aqueous phase by a hydrophobic bilayer, as with a native cell, liposomes 
are able to sustain a membrane potential [261] giving the opportunity to study the effect of ∆Ψ on 
receptor function. However, dictating the orientation of the reconstituted GPCR to obtain meaningful 
results can be a complicating factor. Finally, in contrast to the other mimetics discussed here that 
approximate a bilayer structure, liposomes are unconstrained by a solubilising scaffold structure and 
represent a continuous membrane. This continuous nature allows for native lateral pressure and 
diffusion behaviour of phospholipids and proteins to be studied, and it also allows for the membrane 
components to induce membrane curvature [262]. However, curvature can deviate from that 
experienced in a native membrane when smaller more constrained SUVs are used [263]. 
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Generally for liposomes, there are no limitations with regard to the complexity of the lipid 
composition that can be used, enabling the assembly of extended bilayers based on cellular lipid 
extracts. This also gives the opportunity to define the lipid composition, allowing the study of specific 
lipid interactions. For example, the phenomenon of receptor dimerisation was studied using FRET 
on fluorescently labelled neurotensin receptors in liposomes to show that the presence of cholesterol 
and PE-lipids stimulated dimer formation [264]. 
Unfortunately the large size of liposomes even when using SUVs generally precludes their use 
for solution NMR studies (Figure 4) aiming at a characterisation directly on the intact receptor [237]. 
However, waterLOGSY-based NMR spectroscopy has been successfully applied to study the 
membrane association of the truncated C terminus of the B-type CGRP receptor [265]. With the rapid 
advancement of solid-state NMR techniques, the investigation of GPCRs embedded in liposomes has 
progressed as shown for the investigation of CXCR1 by a combination of magic angle spinning and 
oriented-sample NMR [266]. Further, solid-state NMR has been employed to study ligand binding 
where challenges with studying high-affinity receptor NTR1 were tackled [267]. 
4.5. Membrane Scaffold Protein (MSP) Nanodiscs 
The family of apolipoproteins (Apo) is responsible for facilitating the transport of lipids in the 
bloodstream. Specifically, Apo-A1 is a key structural component of high density lipoprotein (HDL) 
that forms a scaffold surrounding phospholipids and cholesterol [268]. In 2002, Sligar and co-workers 
modified the APOA1 gene, removing the globular domain, and demonstrated that it could assemble 
around phospholipids to form a homogeneous population of particles with a discoidal structure. 
They termed the modified protein an MSP and its complex with lipids a nanodisc [269]. Since then, a 
family of MSPs has been developed by further modifying the number of helical repeats that 
ultimately encircle the nanodisc, each variant forming discs of a different diameter (~6–16 nm Figure 
4) [270–272]. Nanodiscs are formed by mixing detergent-solubilized phospholipids and the MSP 
together followed by subsequently removing the detergent typically with bio-beads. In the presence 
of a detergent-solubilized protein, the latter is also incorporated into the disc, where it is surrounded 
by lipid molecules [273]. 
Structural studies show that nanodiscs contain a patch of lipid bilayer encapsulated with two 
MSPs running antiparallel and stabilized by a zipper-like arrangement of salt bridges between the 
proteins [274]. For an empty disk, the number of phospholipids in each particle range from ~20 to 400 
depending on the MSP construct and the type of phospholipid used, with unsaturated alkyl chains 
packing less tightly into the disc [270,271,275]. Shorter MSPs generating smaller discs may be 
advantageous for solution NMR, as demonstrated by Wagner and co-workers, who found that in 
studies of OmpX, nanodiscs of 8.4 nm provided a suitable compromise between stability and NMR 
data quality [270]. However, it should be considered that with reduced disc sizes, likelihood of 
interactions between the MSP and phospholipid molecules increases, reducing the number of free 
lipids. Smaller discs also increase the risk of spurious interactions between the extramembranous 
regions of the embedded protein and the scaffold protein [273]. Commonly used variants in solution-
state NMR studies of GPCRs are MSP1D1 and MSP1D1E3, which give disc sizes of ~9.6 and ~12 nm, 
respectively, requiring deuteration of the receptor for sufficient spectral quality [166,196]. 
The cryo-EM structure of the SecYEG complex in a nanodisc is consistent with a true lipid bilayer 
with strong density observed for the phospholipid head groups at the surfaces [276], suggesting that 
the electrostatic profile of the bilayer is maintained. Biophysical studies showed that, whilst the DPPC 
and DMPC nanodiscs did display classical crystalline to liquid phase transition, this occurred at a 
higher temperature; a result attributed to the MSP itself causing increased lateral pressure compared 
with a continuous bilayer [277]. Overall, the nanodisc system represents a vast improvement over 
detergents in its ability to emulate a membrane environment. There are still subtle differences that 
need to be taken into account however. For example, the bilayer patch in standard-size nanodiscs 
appears too small for a membrane component to impose curvature or to study the effects of bilayer 
asymmetry. However, technologies such as DNA-corralled nanodiscs (DCNDs) facilitate the 
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formation of much larger structures (≤90 nm diameter) and may allow the study of proteins in the 
context of these phenomena [278]. 
The use of MSPs in both functional and structural studies of GPCRs is becoming increasingly 
common (Table 2), offering insights beyond those carried out in detergent micelles. Using NMR, 
Kofuku et al. compared the dynamics of the β2AR in MSPs and DDM micelles, finding the former to 
cause the ligand-bound β2AR to populate an active conformation to a greater extent and exhibit 
slower rates of conformational exchange [196]. The mimetic system allows the lipid content 
surrounding the protein to be defined and as such probed for specific effects. Nanodiscs were used 
in conjunction with microscale thermophoresis to indicate that more “native-like” PE-rich 
membranes increase the affinity of NTR1 to Gαi [279]. MSPs have also facilitated studies looking at 
the relevance of specific varieties of alkyl tails on receptor activity. It has been demonstrated that the 
presence of DHA within the nanodisc stimulated G protein activation significantly, possibly by 
stabilising receptor conformations that couple more favourably to Gα, as observed by NMR [166]. 
The number of MSP variants continues to expand introducing more advantageous properties. 
Covalently circularised nanodiscs (cNDs) have been used to study a thermostabilised NTR1 by NMR, 
demonstrating higher stability and homogeneity than in detergent [203]. cNDs have also been used 
for the cryo-EM structural determination of NTR1 and Gαi. Interestingly, a higher degree of contact 
was observed between the two proteins relative to detergent based structures. This was attributed to 
the lateral membrane pressure restricting helical movement such that the receptor fits more tightly 
to the G protein [280]. However, non-physiological levels of lateral pressure may be forcing this 
interaction. Using a protein scaffold-based membrane mimetic such as MSP also has the advantage 
of allowing the easy introduction of affinity tags to the complex; this can assist in purification and 
biophysical experiments. Strep-tagged MSP was used to observe receptor dynamics through 
fluorescence changes of individual labelled receptors bound to a streptavidin-coated surface [4]. 
4.6. Styrene Maleic Acid (SMA) Copolymer and Copolymer Variants 
All the membrane mimetic systems discussed thus far require a target protein to first be 
solubilised in detergent before reconstitution into the system of choice. For GPCRs, this initial 
detergent step frequently defines the minimal level of stability required for a receptor to be studied 
and exposes the protein to the potentially disruptive effects of stripping innate phospholipids away 
(discussed above). However, styrene maleic acid copolymers (SMA) offer a way to circumvent this, 
having the effect of excising the target protein within a raft of the lipid membrane it originated from, 
resulting in SMA lipid particles (SMALPs) [281,282]. SMA consists of alternating monomers of 
hydrophobic styrene and hydrophilic maleic acid that can be incorporated into the polymer at 
varying ratios. In solution with a lipid bilayer, the styrene moieties insert into the bilayer interacting 
with the acyl tails. As increasing SMA molecules bind to the membrane, this causes disruption, seen 
as pore formation [283] and ultimately fragmentation [284]. The hydrophilic maleic acid moieties 
reside on the outside of the resulting membrane disc, like a protective cage, rendering the whole 
structure soluble [281]. As the SMA polymer acts to solubilise the entire ~10–40 nm discs (Figure 4) 
of membrane, any proteins within the membranes are solubilised also meaning the protein never 
leaves its native local environment [285]. SMA is only the most commonly used polymer of a growing 
family, as some effort has been placed in altering the hydrophobic and hydrophilic moieties to give 
more favourable physical characteristics such as improved pH and salt tolerance, and tuneable disc 
size [286,287]. 
Previous work has shown that the SMALPs represent a mimetic system that remains faithful to 
the native environment in a number of ways. Small-angle neutron scattering experiments on DMPC-
SMALPs show them to be ~4.6 nm thick, and this is in close alignment with the bilayer thickness of 
DMPC liposomes [288], suggesting that a full bilayer is maintained. Further, phase transition 
temperatures for SMALPs are remarkably close to those of lipids in continuous membrane systems. 
However, the transition is significantly broadened over a larger temperature range, suggesting a drop 
in cooperativity amongst the lipids caused by interactions with the polymer [288]. When studying 
endogenously expressed protein, the physiological accuracy of SMALPs is improved over other 
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systems, as the solubilised protein is isolated with a sample of mixed lipid species, representative of 
the membrane into which the protein was expressed. Coupled with lipidomics, this has helped to 
delineate the different lipid environments within a cell and their relevance for protein function 
[289,290]. 
Structural studies where the protein was solubilised with SMA are few at the time of writing 
and it remains to be proven how useful the system will be. Extant publications do suggest that 
interactions with bound lipids remain intact. A cryo-EM structure of the multidrug transporter AcrB 
exhibited a patch of 24 highly ordered lipids within the AcrB trimer whilst the lipids in the 
surrounding annulus were relatively disordered [291]. Further, the structure of bacterial complex III 
cytochrome oxidase supercomplex displayed a number of surface lipids that could be resolved [292]. 
Of course, it should be noted that SMALPs offer a less controlled system compared to others 
presented here, with little influence over lipids and membrane components that get extracted with 
the protein. 
SMALPs too exhibit increased thermostability [287], making them particularly attractive to 
GPCR research as this may ultimately reduce the need for thermostabilising mutations [282]. The 
only X-ray crystallography structure facilitated by the use of SMALPs was obtained at 2.2 Å for 
bacteriorhodopsin using lipidic cubic phase [293]. More commonly, GPCR-SMALPs have been 
applied to biophysical techniques. Intramolecular FRET has been used to monitor conformational 
changes in SMALP solubilised ghrelin receptors upon ligand binding. Logez et al. critically 
demonstrated G protein activation by GPCR-SMALPs by means of a GTPγS assay [294]. The system 
has also been used in the study of receptor dynamics, where the A2AAR receptor in SMALPs was 
measured by fluorescently tagging the base of TM6. As the environment of the tag was modulated 
by agonist or antagonist binding, conformational changes could be detected. This was used to 
differentiate between agonists of varying efficacy [295]. 
Unfortunately, the large size of SMALPs coupled to relatively heterogeneous preparations 
makes them an unappealing system for solution NMR and as yet no GPCRs have been studied in this 
manner. However, larger SMALPs (>30 nm) have been shown to align in a magnetic field making 
them suited to oriented-sample solid-state NMR. As such, structural information has been gained on 
a small but growing number of membrane proteins isolated in the native-like environment of 
SMALPs, including the CXCR1 receptor [285,296]. 
4.7. Saposin Nanoparticles 
Saposin A (SapA) is a sphingolipid-activating protein, one of four non-enzymatic small proteins 
(A–D) required for the processing of sphingolipids by hydrolases within lysosomes [297]. All 
saposins are able to bind certain lipids as part of their biological function and in 2012 SapA was shown 
to form a disc-like complex with various lipids [298]. SapA monomers are 9 kDa proteins, consisting 
of four α-helices that, if in the apo state, will form a closed conformation at neutral pH. At acidic pH, 
as experienced in the lysosome, SapA will open like a jack knife exposing a hydrophobic inner face 
that can accommodate phospholipids. In complex with LDAO, two SapAs were observed to arrange 
head to tail, forming a scaffold around a well-ordered bilayer-like core of the zwitterionic detergent 
[298]. 
The characteristics of SapA showed clear potential to form the scaffold component of a 
membrane mimetic system, stabilising a phospholipid bilayer patch. Exploring this further, 
Frauenfeld et al. crucially demonstrated that SapA opening and phospholipid uptake could be 
facilitated at neutral pH in the presence of detergent. In the same work, it was shown that a membrane 
protein could be incorporated into the centre of the nanoparticle in analogous fashion to MSP 
nanodiscs, i.e., by incubating SapA, detergent-solubilised lipid and protein together and gradually 
removing the detergent using bio-beads to form a discrete bilayer system [299]. Since then, SapA 
nanoparticles have been shown to be a tuneable system, where adjusting the phospholipid to SapA 
ratio or pH can modify the particle size [300,301]. For occupied nanoparticles, it appears, however, 
that the properties of the embedded protein are primarily dictating the final size of the assembly, 
with a minimal number of SapA molecules recruited to encircle the membrane protein [301,302]. 
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MD simulations suggest that the 16:0–18:1 chain lipid POPC can form a true bilayer patch with 
both leaflets intact similar to the LDAO associated structure [298]. Furthermore, in the recently 
published structure of the bacterial AcrB efflux pump in SapA nanoparticles, a full bilayer can be 
modelled [303]. Accordingly, as expected of an improved bilayer membrane, mimetic hydrophobic 
mismatch would be avoided and the electrostatic effect of the bilayer on the protein, in principle, 
maintained. 
The SapA system seems to show a tendency to minimise the circumference of the bilayer 
surrounding the reconstituted protein [301]. In the structure obtained of the mitochondrial calcium 
uniporter (MCU), whilst the lipids were unresolved, the six encircling SapA units could be seen to 
tilt at a 45° angle to fully span the transmembrane domain [304]. While it is currently not clear 
whether the observed tilt of the scaffold proteins is a more general feature that also applies to other 
saposin complexes, the 45° tilt in this particular case effectively reduces the overall size of the 
nanoparticle. This size minimisation of a bilayer system makes the SapA nanoparticles highly 
attractive for solution NMR (Figure 4). However, this also means that there is only a small lipid phase 
present and it is possible that in some cases only a lipid annulus exists. 
SapA nanodiscs have great potential in the study of GPCRs. Of all the saposins, SapA has been 
shown to be the most promiscuous in the phospholipid species it will interact with [302]. This will 
allow the system to be used to examine effects from a wide range of lipids on GPCR function. Already 
the turkey β1AR receptor in SapA nanoparticles showed agonist-dependent activation and ternary 
complex formation as revealed by NMR, paving the way for more in depth studies to be carried out 
in a lipid bilayer environment [301]. Recently, using the CK receptor as an example, it was shown 
that GPCRs can be extracted directly from biological membranes using SapA. While this could 
circumvent the need for thermostabilising mutations, the high amount of SapA required to solubilise 
the proteins so far has led to low yields, limiting the use on a preparative scale [305]. 
5. Conclusions and Outlook 
Due to the innate difficulties of working with integral membrane proteins, the path to better 
understanding their structure and function has been a difficult one. Of course, GPCRs are no 
exception. However, an increasing appreciation for the relevance of lipid bilayer effects coupled to 
ingenious developments to mimic and study those effects are driving progress in GPCR research.  
Where once detergents and liposomes, as the only controlled systems available, stood at polar 
opposites in terms of molecular size, tractability and physiological accuracy, there is now a family of 
different mimetic systems each being well suited to a range of biophysical techniques. These new 
mimetic systems can be selected also to improve the stability of a GPCR or, crucially, in the case of 
true bilayer-forming systems such as nanodiscs, to shed light on the specific effects of lipid subtypes. 
The latter have been put to particular use in NMR-based GPCR studies, where they have started to 
reveal an ever-richer conformational energy landscape. 
Progress in understanding lipid bilayer effects on GPCR dynamics and structure is set to 
continue. More diverse structural information is being gained on the one hand from static cryo-EM 
and X-ray studies and on the other from solution-based fluorescence and NMR techniques. Further, 
indeed, in the case of GPCRs, computational approaches are well placed to link this information 
together into a cohesive picture. Furthermore, approaches to study membrane proteins in a more 
native environment continue to develop, as shown for example by a recent demonstration of cryo-
EM in a continuous bilayer [306]. 
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